Efficacy of tiotropium–olodaterol fixed-dose combination in COPD

by Derom E, Brusselle GG, Joos GF
Published 2016-12-01

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

by LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R
Published 2018-06-01

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler®...

by Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L
Published 2016-02-01

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

by Cataldo D, Derom E, Liistro G, Marchand E, Ninane V, Peché R, Slabbynck H, Vincken W, Janssens W
Published 2018-07-01

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome

by Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, Peché R, Pilette C, Vincken W, Janssens W
Published 2017-02-01